SCHEDULE 13D: Medinotec Inc. Board Member Gregory Vizirgianakis Discloses 40.4% Beneficial Ownership in Schedule 13D Filing

Gregory Vizirgianakis, a board member of Medinotec Inc., has filed a Schedule 13D disclosing beneficial ownership of 4,750,179 shares, representing 40.4% of the company's common stock.

Summary

• Gregory Vizirgianakis, a current board member of Medinotec Inc., has filed a Schedule 13D with the U.S. Securities and Exchange Commission.
• The filing reports his beneficial ownership of 4,750,179 shares of Medinotec Inc.'s common stock, which represents approximately 40.4% of the Issuer's total outstanding common stock.
• This percentage is calculated based on 11,733,750 shares of common stock outstanding as of January 13, 2025, as reported in Medinotec Inc.'s Form 10-Q filed with the SEC on January 14, 2025.
• The shares were acquired on April 26, 2021, in connection with the issuance of 10,000,000 shares of common stock to founding shareholders at a price of $0.001 per share.
• Mr. Vizirgianakis holds sole voting and dispositive power over these 4,750,179 shares.
• The reporting person has not conducted any transactions in the company's common stock within the past 60 days, aside from the initial acquisition described.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. As a mandatory regulatory disclosure, it doesn't inherently convey positive or negative news. However, the significant insider ownership (40.4%) by a board member can be interpreted as a positive indicator of strong alignment between management and shareholder interests. There are no adverse financial or operational details disclosed.

Positives

• A significant portion of the company's stock (40.4%) is held by a board member, Gregory Vizirgianakis, indicating strong insider alignment and commitment to the company's performance.
• The filing provides transparency regarding a major shareholder's position, which is beneficial for investor understanding of the company's ownership structure.

Risks

• While the reporting person currently has no present plans or proposals for actions such as mergers, liquidations, or changes in control, he explicitly reserves the right to change his intentions and adopt such plans in the future, which could potentially impact the company's strategic direction or shareholder value.

Future Outlook

The reporting person, Gregory Vizirgianakis, currently has no present plans or proposals that would result in actions specified in Item 4 of Schedule 13D, such as mergers, liquidations, or changes in the company's business or corporate structure. However, he explicitly reserves the right to change his intentions and adopt future plans or proposals, including acquiring additional common stock, disposing of shares, discussing company affairs with management or other stakeholders, or taking any other action he deems appropriate to enhance shareholder value.

Management Comments

• "The Reporting Person has no present plans or proposals which relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4."
• "The Reporting Person may, from time to time, determine to acquire additional Common Stock, to dispose of some or all of his Common Stock, discuss the Issuer's business, operations or other affairs with the Issuer's management, board of directors, shareholders, or others or take such other action as he deems appropriate."
• "The Reporting Person reserves the right to change his intentions and adopt plans or proposals in the future that could result in any of the transactions specified in clauses (a) through (j) of Item 4, or any other transaction which the Reporting Person believes could enhance shareholder value."

Industry Context

This Schedule 13D filing is a standard regulatory disclosure required by the U.S. Securities and Exchange Commission when an individual or group acquires beneficial ownership of more than 5% of a company's voting class of securities. It serves to provide transparency regarding significant shareholder positions, which is a fundamental aspect of market integrity and investor protection. The filing itself does not provide specific insights into broader industry trends but rather focuses on the ownership structure of Medinotec Inc. within the regulatory framework for publicly traded companies.

Comparison to Industry Standards

• This filing is a routine regulatory disclosure (Schedule 13D) mandated by the SEC for beneficial ownership exceeding 5%. Its primary purpose is to ensure transparency regarding significant shareholder positions, aligning with global best practices for corporate disclosure.
• The 40.4% beneficial ownership by a current board member, Gregory Vizirgianakis, represents a substantial insider stake. This level of insider ownership is generally viewed positively in corporate governance, as it strongly aligns the interests of a key decision-maker with those of other shareholders, potentially fostering long-term value creation.
• The document does not contain operational or financial performance data, thus precluding a direct comparison of Medinotec Inc.'s results against specific industry benchmarks or comparable companies' performance.

Stakeholder Impact

• **Shareholders**: Provides transparency regarding a substantial insider ownership stake, which may be viewed as a sign of confidence from a key board member and could influence perceptions of corporate stability and alignment of interests.
• **Management/Board**: Highlights the significant influence and vested interest of Gregory Vizirgianakis, a current board member, due to his substantial ownership position.

Next Steps

• The Reporting Person may, from time to time, determine to acquire additional shares of Medinotec Inc. common stock.
• The Reporting Person may, from time to time, determine to dispose of some or all of his shares of Medinotec Inc. common stock.
• The Reporting Person may engage in discussions regarding Medinotec Inc.'s business, operations, or other affairs with the company's management, board of directors, shareholders, or other parties.
• The Reporting Person reserves the right to change his intentions and adopt future plans or proposals that could lead to transactions specified in Item 4 of Schedule 13D (e.g., mergers, liquidations, changes in control) or other actions aimed at enhancing shareholder value.

Key Dates

Keywords

Medinotec Inc., Gregory Vizirgianakis, Schedule 13D, Beneficial Ownership, Common Stock, SEC Filing, Shareholder, Corporate Governance, Insider Ownership, Investment